Luye Pharma (Singapore) Pte Ltd is a wholly owned subsidiary of Luye Pharma Group Ltd, a public-listed company in Hong Kong and a leading pharmaceutical group in China.
Create a viable and profitable business in the development and marketing of evidence based and safe natural medicines for the benefit of everybody.
Our primary objective is to identify, commercialise and market evidence-based natural and traditional Chinese and oriental medicines. To achieve this objective, we are supported by the research and development departments in Luye’s diverse group of companies including WBL-Peking University Biotech Co., Ltd (WPU).
We are also open to market external brands of natural products that are backed by strong clinical evidence.
Our business activities include product development, innovative marketing, e-health commerce, health publication, distribution of pharmaceutical and nutraceutical products and value-added investment.